208 related articles for article (PubMed ID: 1824955)
21. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
Seeman P; Guan HC; Niznik HB
Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
[No Abstract] [Full Text] [Related]
22. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats.
Henry JM; Joseph JA; Kochman K; Roth GS
Brain Res; 1987 Aug; 418(2):334-42. PubMed ID: 2960421
[TBL] [Abstract][Full Text] [Related]
23. In vivo labelling of rat brain dopamine D-2 receptors. Stereoselective blockade by the D-2 antagonist raclopride and its enantiomer of 3H-spiperone, 3H-N,N-propylnorapomorphine and 3H-raclopride binding in the rat brain.
Köhler C; Karlsson-Boethius G
J Neural Transm; 1988; 73(2):87-100. PubMed ID: 2974879
[TBL] [Abstract][Full Text] [Related]
24. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Levant B
Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
[TBL] [Abstract][Full Text] [Related]
25. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
Hess EJ; Battaglia G; Norman AB; Creese I
Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
[TBL] [Abstract][Full Text] [Related]
27. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M
Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
[TBL] [Abstract][Full Text] [Related]
28. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
Hall H; Wedel I
Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
[TBL] [Abstract][Full Text] [Related]
30. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
Kula NS; George T; Baldessarini RJ
Brain Res Dev Brain Res; 1992 Apr; 66(2):286-9. PubMed ID: 1535031
[TBL] [Abstract][Full Text] [Related]
31. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
32. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum.
Norman AB; Wachendorf TJ; Sanberg PR
Life Sci; 1989; 44(13):831-6. PubMed ID: 2648096
[TBL] [Abstract][Full Text] [Related]
33. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
Crawford CA; Rowlett JK; McDougall SA; Bardo MT
Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
Hall H; Wedel I; Halldin C; Kopp J; Farde L
J Neurochem; 1990 Dec; 55(6):2048-57. PubMed ID: 1977888
[TBL] [Abstract][Full Text] [Related]
35. Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockade.
Neve KA; Loeschen S; Marshall JF
Brain Res; 1985 Mar; 329(1-2):225-31. PubMed ID: 3156659
[TBL] [Abstract][Full Text] [Related]
36. Chronic uridine treatment reduces the level of [3H]spiperone-labelled dopamine receptors and enhances their turnover rate in striatum of young rats: relationship to dopamine-dependent behaviours.
Farabegoli C; Merlo Pich E; Cimino M; Agnati LF; Fuxe K
Acta Physiol Scand; 1988 Feb; 132(2):209-16. PubMed ID: 2906500
[TBL] [Abstract][Full Text] [Related]
37. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
[TBL] [Abstract][Full Text] [Related]
38. Effects of heavy metal cations, sulfhydryl reagents and other chemical agents on striatal D2 dopamine receptors.
Scheuhammer AM; Cherian MG
Biochem Pharmacol; 1985 Oct; 34(19):3405-13. PubMed ID: 3931643
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
[TBL] [Abstract][Full Text] [Related]
40. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
Dewar KM; Montreuil B; Grondin L; Reader TA
J Pharmacol Exp Ther; 1989 Aug; 250(2):696-706. PubMed ID: 2527300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]